OVID THERAPEUTICS INC shareholders Q3 2023

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

OVID THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$5,06820.50%
Madison Avenue Partners, LP 3,648,509$14,010,2751.99%
CHI Advisors LLC 864,822$3,320,9161.32%
EcoR1 Capital, LLC 6,117,400$23,490,8160.79%
Rubric Capital Management LP 5,445,910$20,912,2940.78%
BVF INC/IL 6,851,051$26,308,0360.71%
Artal Group S.A. 2,500,000$9,6000.41%
DCF Advisers, LLC 30,430$116,8510.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 458,700$1,761,4080.04%
ACADIAN ASSET MANAGEMENT LLC 1,701,228$6,5310.03%
UBS OCONNOR LLC 150,000$576,0000.02%
Empowered Funds, LLC 107,800$413,9520.01%
BAILARD, INC. 12,600$48,3840.00%
Connor, Clark & Lunn Investment Management Ltd. 81,173$311,7040.00%
Jump Financial, LLC 15,811$60,7140.00%
MetLife Investment Management, LLC 31,717$121,7930.00%
SG Americas Securities, LLC 26,064$1000.00%
AMERICAN INTERNATIONAL GROUP, INC. 29,759$114,2750.00%
Renaissance Technologies 80,800$3100.00%
WELLS FARGO & COMPANY/MN 444,966$1,708,6690.00%
External links

This page lists OVID THERAPEUTICS INC's shareholders in Q3 2023. To view OVID THERAPEUTICS INC's shareholder history, click here.